Affimed (NASDAQ: AFMD) had its price target raised by analysts at Laidlaw from $15.00 to $25.00. They now have a "buy" rating on the stock.
Affimed (NASDAQ: AFMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Affimed Reports First Quarter 2024 Financial Results & Business Update
Affimed to Report First Quarter 2024 Financial Results & Corporate Update on June 12, 2024
Affimed (NASDAQ: AFMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.